Abstract
Patients who have acute coronary syndrome complicated by heart failure have increased short- and long-term morbidity and mortality. Besides the proven action in reducing cardiovascular events and mortality, statins also reduce the risk of developing heart failure after acute coronary syndrome. The pathways responsible for this benefit are likely a result of the "pleiotropic" actions of statins. The ongoing trials of statins in patients who have heart failure will help to further characterize this benefit.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have